(Q46730440)

24 December 2017

title

Binding properties of [3H]MS-377, a novel sigma receptor ligand, to rat brain membranes (English)

1 reference

24 December 2017

author name string

Karasawa J

series ordinal

1

1 reference

24 December 2017

Takahashi S

series ordinal

2

1 reference

24 December 2017

Horikomi K

series ordinal

3

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

24 December 2017

European Journal of Pharmacology

published in

1 reference

24 December 2017

volume

400

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

51-57

1 reference

24 December 2017

Evidence for a multi-site model of the rat brain sigma receptor

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Characterization of the binding of [3H](+)-pentazocine to sigma recognition sites in guinea pig brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Open clinical trial on the sigma ligand panamesine in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Phencyclidine and sigma opiate receptors in brain: biochemical and autoradiographical differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Purification, molecular cloning, and expression of the mammalian sigma1-binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Autoradiographic identification and characterization of sigma receptors in guinea pig brain using [3H]1(cyclopropylmethyl)-4-(2'-(4''-fluorophenyl)-2'-oxoethyl) piperidine ([3H]DuP 734), a novel sigma receptor ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Role of (+)-SKF-10,047-sensitive sub-population of sigma 1 receptors in amelioration of conditioned fear stress in rats: association with mesolimbic dopaminergic systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Sigma-1 receptors modulate functional activity of rat splenocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Efficacy and safety of an opiate sigma-receptor antagonist (SL 82.0715) in schizophrenic patients with negative symptoms: an open dose-range study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

NE-100, a novel sigma receptor ligand: in vivo tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Autoradiographic characterization of binding sites for [3H]NE-100 in guinea pig brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Cloning and characterization of a mouse sigma1 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 sigma receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

A proposal for the classification of sigma binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Cloning and functional characterization of a sigma receptor from rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Receptor mechanisms in antipsychotic drug action: focus on sigma receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Sigma receptors. Putative links between nervous, endocrine and immune systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Characteristics of binding of [3H]NE-100, a novel sigma-receptor ligand, to guinea-pig brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Sigma (σ) antagonist BMY 14802 prevents methamphetamine-induced sensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

sigma Receptor antagonists block the development of sensitization to cocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Pharmacotherapy of cocaine abuse: preclinical development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900348-4

10.1016/S0014-2999(00)00348-4

7 January 2021

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017